David Chatenet
Laval, QC H7V1B7, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Selective Nanobody-Derived Minibodies Targeting Galectin-1 and -7 Reveal Non-Redundant Glyco-Immune Functions and Therapeutic Potential in Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: April 29, 2026
Nanobody-Based Characterization of Galectin-13 Reveals Immunomodulatory and Tumor-Promoting Functions.
Journal: The Journal of biological chemistry
Published: March 15, 2026
Network-based allosteric analysis of galectin-7: Key residues dictate functional communication and stability.
Journal: Protein science : a publication of the Protein Society
Published: October 09, 2025
Structure-activity relationships of contulakin-G: Design, synthesis, and characterization of Thr10 analogs for pain modulation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 08, 2025
Development of Galectin-7-Specific Nanobodies: Implications for Immunotherapy and Molecular Imaging in Cancer.
Journal: Journal of medicinal chemistry
Published: April 10, 2025
Development and Use of a Galectin-1-Specific Nanobody for Tumor Imaging and Elucidating the Role of Galectin‑1 in Cancer.
Journal: ACS pharmacology & translational science
Published: March 10, 2025
Immunomodulation With Local, Sustained Delivery of Pituitary Adenylate Cyclase Activating Polypeptide Results in Improved Functional Recovery in Stroke-Injured Mice.
Journal: Advanced healthcare materials
Published: February 11, 2025
Enhanced Gαq Signaling in TSC2-Deficient Cells Is Required for Their Neoplastic Behavior.
Journal: American journal of respiratory cell and molecular biology
Published: November 08, 2024
Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor.
Journal: Cellular signalling
Published: September 04, 2024
Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators.
Journal: Journal of medicinal chemistry
Published: August 03, 2024
Urotensin II Receptor Modulation with 1,3,4-Benzotriazepin-2-one Tetrapeptide Mimics.
Journal: Journal of medicinal chemistry
Published: October 06, 2023
Last Updated: 09/26/2026